Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Analyst Ratings
Moderate Buy
5 Buy
4 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GDRX Stock 12 Month Forecast
Average Price Target
$6.14
▲(45.50%Upside)
| Highest Price Target$8.00 | Average Price Target$6.14 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$4.5
Hold
6.64%
Upside
Reiterated
06/05/25
GoodRx Holdings demonstrates strong financial performance and strategic growth initiatives, but faces challenges with overvaluation, technical pressures, and macroeconomic risks. The company's robust financial health and strategic leadership changes could mitigate some risks and support future growth.
Citi
$6.75→$7
Buy
65.88%
Upside
Reiterated
05/14/25
KeyBanc
$6
Buy
42.18%
Upside
Reiterated
05/14/25
UBS
$6→$5.25
Hold
24.41%
Upside
Reiterated
05/13/25
Truist Financial
―
Hold
―
Reiterated
05/12/25
Goldman Sachs
$6→$5
Hold
18.48%
Upside
Reiterated
05/09/25
Morgan Stanley
$6
Hold
42.18%
Upside
Reiterated
05/08/25
Leerink Partners
$7
Buy
65.88%
Upside
Reiterated
05/08/25
TD Cowen
$8
Buy
89.57%
Upside
Reiterated
05/08/25
Wells Fargo
$7
Buy
65.88%
Upside
Reiterated
05/08/25
Bank of America Securities
$4.75→$4
Sell
-5.21%
Downside
Reiterated
05/07/25
Mizuho Securities
$5
Hold
18.48%
Upside
Reiterated
03/03/25
Raymond James
$9
Buy
113.27%
Upside
Reiterated
02/27/25
RBC Capital
$6
Buy
42.18%
Upside
Reiterated
02/27/25
J.P. Morgan
$7
Buy
65.88%
Upside
Reiterated
11/26/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$4.5
Hold
6.64%
Upside
Reiterated
06/05/25
GoodRx Holdings demonstrates strong financial performance and strategic growth initiatives, but faces challenges with overvaluation, technical pressures, and macroeconomic risks. The company's robust financial health and strategic leadership changes could mitigate some risks and support future growth.
Citi
$6.75→$7
Buy
65.88%
Upside
Reiterated
05/14/25
KeyBanc
$6
Buy
42.18%
Upside
Reiterated
05/14/25
UBS
$6→$5.25
Hold
24.41%
Upside
Reiterated
05/13/25
Truist Financial
―
Hold
―
Reiterated
05/12/25
Goldman Sachs
$6→$5
Hold
18.48%
Upside
Reiterated
05/09/25
Morgan Stanley
$6
Hold
42.18%
Upside
Reiterated
05/08/25
Leerink Partners
$7
Buy
65.88%
Upside
Reiterated
05/08/25
TD Cowen
$8
Buy
89.57%
Upside
Reiterated
05/08/25
Wells Fargo
$7
Buy
65.88%
Upside
Reiterated
05/08/25
Bank of America Securities
$4.75→$4
Sell
-5.21%
Downside
Reiterated
05/07/25
Mizuho Securities
$5
Hold
18.48%
Upside
Reiterated
03/03/25
Raymond James
$9
Buy
113.27%
Upside
Reiterated
02/27/25
RBC Capital
$6
Buy
42.18%
Upside
Reiterated
02/27/25
J.P. Morgan
$7
Buy
65.88%
Upside
Reiterated
11/26/24
Best Analysts Covering GoodRx Holdings
1 Month
xxx
Success Rate
9/18 ratings generated profit
Average Return
+1.17%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.17% per trade.
3 Months
xxx
Success Rate
8/13 ratings generated profit
Average Return
+4.34%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +4.34% per trade.
1 Year
Success Rate
12/13 ratings generated profit
Average Return
+21.43%
reiterated a sell rating last month
Copying Allen Lutz's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +21.43% per trade.
2 Years
xxx
Success Rate
12/13 ratings generated profit
Average Return
+23.77%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 92.31% of your transactions generating a profit, with an average return of +23.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GDRX Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
15
9
4
5
7
Buy
6
7
7
3
2
Hold
11
8
5
6
7
Sell
3
3
2
2
2
Strong Sell
0
0
0
0
0
total
35
27
18
16
18
Each month's total comprises the sum of three months' worth of ratings.
GDRX Financial Forecast
GDRX Stock Forecast FAQ
What is GDRX’s average 12-month price target, according to analysts?
Based on analyst ratings, GoodRx Holdings’s 12-month average price target is 6.14.
What is GDRX’s upside potential, based on the analysts’ average price target?
GoodRx Holdings has 45.50% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GDRX a Buy, Sell or Hold?
GoodRx Holdings has a consensus rating of Moderate Buy which is based on 5 buy ratings, 4 hold ratings and 1 sell ratings.
What is GoodRx Holdings’s price target?
The average price target for GoodRx Holdings is 6.14. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $8.00 ,the lowest forecast is $4.00. The average price target represents 45.50% Increase from the current price of $4.22.
The highest analyst price target is $8.00 ,the lowest forecast is $4.00. The average price target represents 45.50% Increase from the current price of $4.22.
What do analysts say about GoodRx Holdings?
GoodRx Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of GDRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.